Understand Your Ovarian Cancer Diagnosis
Clear Guidance and Support for Your Diagnosis
Ovarian cancer begins in the ovaries and can differ in type, stage, and severity. Your pathology report offers detailed insights into the tumor’s characteristics, helping you and your care team understand the condition and make informed decisions about treatment.
Our expert pathologists at HONEST Pathology break down your report in understandable language, offering compassionate guidance so you feel informed and supported every step of the way.
Informed Decisions
Better Conversations
Leave Empowered
Peace of Mind
Guided Next Steps
Ready to Understand Your Diagnosis?
Don’t let confusion hold you back. Schedule an online consultation with our expert pathologists and get clear, personalized answers about your diagnosis — all from the comfort of home.
Frequently Asked Questions
Tumor grade indicates how aggressive the cancer cells appear under the microscope. Higher-grade tumors may require more intensive treatment, and understanding the grade helps your care team tailor the best approach.
Early-stage ovarian cancer is confined to the ovaries, while advanced stages have spread to other areas. Knowing the stage helps determine treatment options and prognosis, and our experts clarify these details in understandable terms.
Subtypes are identified by examining the tumor’s cellular structure and characteristics under the microscope. Clear identification helps your doctors choose targeted therapies and make informed decisions.
Biomarkers provide information about how the cancer may behave and respond to treatment. Understanding your biomarker results can guide personalized therapy and improve outcomes.
Absolutely. All documents and communications are handled with full confidentiality, in compliance with HIPAA and international medical privacy standards.
Reports may be reviewed whenever new tests are conducted or treatment plans change. Regular review ensures that you and your care team are always making decisions based on the most accurate information.
Certain genetic mutations, such as BRCA1 or BRCA2, can influence how the cancer develops and responds to therapy. Knowing these results helps guide personalized treatment strategies.
Surgical margins show whether cancer cells remain after surgery, and tumor spread indicates how far the disease has progressed. Both factors are critical in planning additional treatment and follow-up care.
Histological patterns describe the tumor’s microscopic structure. Recognizing these patterns allows your care team to select the most effective therapies and predict how the cancer may behave.
